Summary
Photodynamic therapy with topically applied δ-aminolaevulinic acid is used to treat skin tumours by employing endogenously formed porphyrins as photosensitizers. This study examines the time course of porphyrin metabolite formation after topical application of δ-aminolaevulinic acid. Porphyrin biosynthesis in human skin tumours (basal cell carcinoma, squamous cell carcinoma), in psoriatic lesions, and in normal skin was investigated. Skin areas were treated with δ-aminolaevulinic acid, and levels of total porphyrins, porphyrin metabolites and proteins were measured in samples excised after 1, 2, 4, 6, 9, 12 and 24 h. There was an increase in porphyrin biosynthesis in all tissues with maximum porphyrin levels in tumours between 2 and 6 h and in psoriatic lesions 6 h after treatment. The pattern of porphyrins showed no significant difference between normal and neoplastic skin, protoporphyrin being the predominant metabolite. The results suggest that optimum irradiation time for superficial epithelial skin tumours may be as soon as 2 h after application of δ-aminolaevulinic acid, whereas for treatment of psoriatic lesions an application time of 6 h is more suitable.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abels, C., Heil, P., Dellian, M., Kuhnle, G. E. H., Baumgartner, R. & Goetz, A. E. (1994). In vivo kinetics and spectra of 5-aminolevulinic acid induced fluorescence in an amelanotic melanoma of the hamster. Br J Cancer 70: 826–833.
Bloomer, J. R., Brenner, D. A. & Mahoney, M. J. (1997). Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria. J Clin Invest 60: 1354–1361.
Boehncke, W. H., Sterry, W. & Kaufmann, R. (1994). Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343: 801
Bolsen, K., Lang, K., Verwohlt, B., Fritsch, C. & Goerz, G. (1996). In vitro induction of porphyrin biosynthesis in various human cells after incubation with δ-aminolevulinic acid. Arch Dermatol Res 288: 320A
Calzavara-Pinton, P. G. (1995). Repetitive photodynamic therapy with topical δ-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol Biol 29: 53–57.
Fritsch, C., Becker-Wegerich, P. M., Schulte, K. W., Neuse, W., Lehmann, P., Ruzicka, T. & Goerz, G. (1996a). Treatment of a large superficial basal cell carcinoma of the breast with combination of photodynamic therapy and surgery controlled by photodynamic diagnosis. Hautarzt 47: 438–442.
Fritsch, C., Verwohlt, B., Bolsen, K., Ruzicka, T. & Goerz, G. (1996b). Influence of topical photodynamic therapy with 5-aminolevulinic acid on the porphyrin metabolism. Arch Dermatol Res 288: 517–521.
Fritsch, C., Abels, C., Goetz, G., Stahl, W., Bolsen, K., Ruzicka, T., Goerz, G. & Sies, H. (1997a). Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol Chem 378: 51–57.
Fritsch, C., Neuse, W., Ruzicka, T. & Goerz, G. (1997b). Photodynamische Diagnostik in der Dermatologie. In Handbuch der Dermatologischen Phototherapie und Photodiagnostik. Krutman J and Hönigsmann H, (eds), pp. 331–356, Springer: Berlin
Fritsch, C., Batz, J., Bolsen, K., Schulte, K. W., Zumdick, M., Ruzicka, T. & Goerz, G. (1997c). Ex-vivo application of ALA induces high and specific porphyrin levels in human skin tumors. Possible basis for selective photodynamic therapy. Photochem Photobiol 66: 114–118.
Fritsch, C., Goerz, G. & Ruzicka, T. (1997d). Photodynamic therapy in dermatology. A review. Arch Dermatol 134: 207–214.
Fritsch, C., Homey, B., Stahl, W., Lehmann, P., Ruzicka, T. & Sies, H. (1998). Preferential relative porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester. Photochem Photobiol 68: 218–221.
Goerz, G., Link-Mannhardt, N., Bolsen, K., Zumdick, M., Fritsch, C. & Schürer, N. Y. (1995). Porphyrin concentrations in various human tissues. Exp Dermatol 4: 218–228.
Goetz AE Lumper, W., Fritsch, C., Müller, W., Feyh, J., Conzen, P. & Brendel, W. (1990). Changes in tumor and adjacent tissue perfusion after photodynamic therapy. Eur Surg Res 22 (Suppl 1): 59
Goff, B., Bachor, R., Kollias, N. & Hasan, T. (1992). Effects of photodynamic therapy with topical application of 5-aminolevulinc acid on normal skin of hairless guinea pigs. J Photochem Photobiol B 15: 139–251.
Grant, W. E., Hopper, C., Macrobert, A. J., Speight, P. M. & Bown, S. G. (1993). Photodynamic therapy of oral cancer: photosensitisation with systemic aminolevulinic acid. Lancet 342: 147–148.
Hanania, J. & Malik, Z. (1992). The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett 65: 127–131.
Hua, Z., Gibson, S. L., Foster, T. M. & Hilf, R. (1995). Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 55: 1723–1731.
Iinuma, S., Bachor, R., Flotte, T. & Hasan, T. (1995). Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urology 153: 802–806.
Kennedy, J. C., Pottier, R. H. & Pross, D. C. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol 6: 143–148.
Kriegmair, M., Baumgartner, R., Knüchel, R., Stepp, H., Hofstädter, F. & Hofstetter, A. (1996). Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155: 105–109.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275.
Malik, Z., Kostenich, G., Roitman, L., Ehrenberg, B. & Orenstein, A. (1995). Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol Biol 28: 213–218.
Martin, A., Tope, W. D., Grevelink, J. M., Starr, J. C., Fewkes, J. L., Flotte, T. J., Deutsch, T. F. & Anerson, R. R. (1995). Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic therapy. Arch Dematol Res 287: 665–674.
Pass, H. I. (1993). Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 85: 443–453.
Peng, Q., Moan, J., Warloe, T., Nesland, J. M. & Rimington, C. (1992). Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 52: 433–443.
Peng, Q., Warloe, T., Moan, J., Heyerdahl, H., Steen, H. B., Nesland, J. M. & Giercksky, G. E. (1995). Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62: 906–913.
Regula, J., Macrobert, A. J., Gorchein, A., Buonaccorsi, G. A., Thorpe, S. M., Spencer, G. M., Hatfield, A. R. W. & Bown, S. G. (1994). Photosensitization and photodynamic therapy of esophageal, duodenal, and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX – a pilot study. Gut 36: 67–75.
Seubert, A. & Seubert, S. (1982). High-performance liquid chromatographic analysis of porphyrins and their isomers with radial compression columns. Anal Biochem 124: 303–307.
Sroka, R., Beyer, W., Gossner, L., Sassy, T., Stocker, S. & Baumgartner, R. (1996). Pharmacokinetics of 5-aminolevulinic-acid-induced porphyrins in tumour-bearing mice. J Photochem Photobiol Biol 34: 13–19.
Stringer, M. R., Collins, P., Robinson, D. J., Stables, G. I. & Sheehan-Dare, R. A. (1996). The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for photodynamic therapy. J Invest Dermatol 107: 76–81.
Svanberg, K., Anderson, T., Killander, D., Wang, I., Stenram, U., Andersson-Engels, S., Berg, R., Johansson, J. & Svanberg, S. (1994). Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 130: 743–751.
Szeimies, R. M., Sassay, T. & Landthaler, M. (1994). Penetration potency of topical applied delta aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 59: 73–76.
Veen van der, N., Bruijn de, H. S., Berg, R. J. W. & Star, W. M. (1996). Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. Br J Cancer 73: 925–930.
Warloe, T., Peng, Q., Steen, H. B. & Giercksky, K. E. (1992). Localization of porphyrins in human basal cell carcinoma and normal skin tissue induced by topical application of 5-aminolevulinic acid. In Photodynamic Therapy and Biomedical Lasers. Spinelli P, Del Fante M and Marchesini R (eds), pp. 454–458. Elsevier Science Publishers B.V., Milan
Wolf, P., Rieger, E. & Kerl, H. (1993). Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 28: 17–21.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Fritsch, C., Lehmann, P., Stahl, W. et al. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinic acid. Br J Cancer 79, 1603–1608 (1999). https://doi.org/10.1038/sj.bjc.6690255
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690255
Keywords
This article is cited by
-
Tageslicht-photodynamische Therapie
Der Hautarzt (2018)
-
Anti-microbial photodynamic therapy: useful in the future?
Lasers in Medical Science (2007)
-
Photodynamische Therapie nichtonkologischer Indikationen
Der Hautarzt (2007)